These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6394659)

  • 21. The antiaggregatory effectiveness of PGI2 and its binding to specific platelet receptors. A comparative study.
    Jaschonek K; Renn W; Weisenberger H
    Prog Clin Biol Res; 1987; 242():13-8. PubMed ID: 3313410
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood platelets and extracorporeal circulation; kinetic studies on dogs on cardiopulmonary bypass.
    de Leval MR; Hill JD; Mielke CH; Macur F; Gerbode F
    J Thorac Cardiovasc Surg; 1975 Jan; 69(1):144-51. PubMed ID: 1110575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and experimental study on platelet--preserving effect of prostaglandin E1 during extracorporeal circulation].
    Osada H; Kawada T; Hoson M; Funaki S; Arase K; Hiekata T; Noguchi T
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Oct; 30(10):1656-63. PubMed ID: 6891710
    [No Abstract]   [Full Text] [Related]  

  • 25. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombocyte functional activity and ultrastructure during artificial circulation with membrane oxygenation of the blood].
    Beliakov NA; Vashkinel' VK; Zhuravleva IN; Simbirtsev SA; Petrash VV
    Anesteziol Reanimatol; 1980; (6):26-9. PubMed ID: 7212359
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation.
    Cottrell ED; Kappa JR; Stenach N; Fisher CA; Tuszynski GP; Switalska HI; Addonizio VP
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):535-41. PubMed ID: 2459560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional changes of platelet and its preservation during and after extracorporeal circulation (author's transl)].
    Isomura K
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Sep; 27(9):1235-49. PubMed ID: 501169
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
    Wilson NH; Armstrong RA; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():491-5. PubMed ID: 2821762
    [No Abstract]   [Full Text] [Related]  

  • 34. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative and functional changes in platelets and their preservation during extracorporeal circulation.
    Miyauchi Y; Isomura K
    J Cardiovasc Surg (Torino); 1982; 23(5):383-90. PubMed ID: 7130259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies with the stabilized epoprostenol analogue taprostene. Effect on platelets and erythrocytes.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Jul; 40(7):817-22. PubMed ID: 2222558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
    Wachtogel YT; Musial J; Jenkin B; Niewiarowski S; Edmunds LH; Colman RW
    J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S; Nieuweboer B; Matthes S; Schillinger E
    Prog Clin Biol Res; 1989; 301():365-9. PubMed ID: 2477855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.